Invesaro

Stocks NEUP Earnings

Earnings

Neuphoria Therapeutics Inc. (NEUP) earnings

Quarterly results of Neuphoria Therapeutics Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when NEUP files with the SEC.

Next earnings date

Neuphoria Therapeutics Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q4 FY2026

In Q4 FY2026 (ended June 30, 2026) Neuphoria Therapeutics Inc. reported revenue of - and a net loss of $4.9M.

Filed with the SEC on September 18, 2026.

Revenue by quarter
Q2 25: $662.7K $662.7K Q2 25Q3 25: $15M $15M Q3 25
Net income by quarter
Q1 25: -$804.8K -$804.8K Q1 25Q2 25: -$1.9M -$1.9M Q2 25Q3 25: $11.3M $11.3M Q3 25Q4 25: -$8.9M -$8.9M Q4 25Q1 26: -$9.9M -$9.9M Q1 26Q2 26: $1.9M $1.9M Q2 26Q3 26: -$505.1K -$505.1K Q3 26Q4 26: -$4.9M -$4.9M Q4 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q4 FY2026June 30, 2026---$4.9M-
Q3 FY2026March 31, 2026---$505.1K-$0.09
Q2 FY2026December 31, 2025--$1.9M-$0.77
Q1 FY2026September 30, 2025---$9.9M-$4.41
Q4 FY2025June 30, 2025---$8.9M-
Q3 FY2025March 31, 2025$15M-$11.3M$6.55
Q2 FY2025December 31, 2024$662.7K--$1.9M-$1.79
Q1 FY2025September 30, 2024---$804.8K-$0.62

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Neuphoria Therapeutics Inc.'s next earnings date?

Neuphoria Therapeutics Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when NEUP reports

Follow NEUP and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when NEUP files with the SEC.

Source: quarterly figures Neuphoria Therapeutics Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Neuphoria Therapeutics Inc.